Labcorp finalizes acquisition of select assets of Invitae

Labcorp finalizes acquisition of select assets of Invitae
Invitae plunges amid report it may file for bankruptcy within weeks
Invitae jumps on news of merger offer from Exact Sciences
85.95KUSD
Type
Common Stock
Exchange
PINK
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US46185L1035
CUSIP
46185L103
Sector
Healthcare
Industry
Diagnostics & Research
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-0.51
Book Value
-3.78
Dividend Share
-
Dividend Yield
-
Earnings Share
-5.36
Wall Street Target Price
0.30
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
-0.31
EPS Estimate Next Quarter
-0.31
Most Recent Quarter
-
Revenue TTM
481,583,008
Gross Profit TTM
99,047,000
EBITDA
-353,936,992
Profit Margin
-299.14%
Return On Assets TTM
-23.70%
Return On Equity TTM
-863.95%
Revenue Per Share TTM
1.864
Qtly Revenue Growth YOY
-9.20%
Diluted Eps TTM
-5.36
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
0.0002
Price Book MRQ
3.3178
Enterprise Value Revenue
2
Enterprise Value EBITDA
0
113.63
0.65%61.97
0.24%117.35
-3.83%168.83
-3.33%1041.30
-2.98%446.91
-2.62%343.36
-2.34%609.20
-2.11%525.90
-1.50%164.94
-0.84%